Breakthrough Treatment
The Hemastyl® Wound Gel
Radiographic and visual evidence shows this patented technology closed combination hard and soft tissue wounds 500% faster than competitor products, even for patients with chronic wounds and diabetes.
Rx: Under the supervision of a healthcare professional, indicated for the management of 1st degree burns and 2nd degree superficial burns, wounds such as stasis ulcers, pressure ulcers, diabetic ulcers, lacerations, abrasions, skin tears, surgical incision sites, device insertion site wounds, graft sites, and donor sites.
OTC: Indicated for the management of minor abrasions, minor cuts, minor lacerations, and minor scalds.
Clinical Evidence
Clinical Evidence Supporting Hemastyl®
A series of case-based evaluations were conducted under real-world use conditions to assess product performance. These case studies document observable changes in wound appearance over time, including coverage, surface condition, and user-reported comfort. Consistent application protocols were used to support objective visual comparison across timepoints. While individual results may vary, these findings provide supportive evidence of Hemastyl®’s performance in practical use.
Additionally, data from our 39 enrolled patients using Hemastyl technology revealed that the feeling in their toes, feet and limbs returned, and limbs began to feel warm after treatment. 39 total complex nonhealing wounds had a 95% healing rate, 19 of which were diagnosed for an amputation. All 19 amputations were averted.
Note: Prior to enrollment, patients were treated with the above-listed medications for a period of three months with no observable healing response. The feasibility population consisted of patients with multiple risk factors and comorbidities associated with impaired wound healing.
Science
Hemastyl® Wound Gel
Use in Wound Care
Pressure injuries: Hemastyl gel can be used with all stages of pressure injuries. Due to its antimicrobial benefits, it is a good option for wounds that need microbial reduction.
Venous ulcers: The use of Hemastyl gel on venous stasis ulcers is less common due to the risk of overhydrating the wound and macerating the periwound. Since venous stasis ulcers are commonly higher output wounds, take care when using a wound hydrating treatment.
Arterial ulcers: This ulcer etiology typically has a dryer wound bed with no to minimal drainage. This makes the choice to use Hemastyl gel appropriate for open arterial ulcers. As always, protect and keep stable dry eschar on heels and toes to prevent infection and wound deterioration until a vascular specialist evaluates the patient.
Diabetic wounds: You can use this treatment on neuropathic wounds, such as diabetic foot ulcers, which often have some level of arterial involvement as a secondary cause. With these wounds, be mindful of dry eschar on the heel and toes (like with arterial ulcers) until the patient undergoes a thorough vascular assessment.
Traumatic wounds: Hemastyl gel can be beneficial on traumatic wounds as it can decrease pain in the wound bed. Keeping the wound bed moist with frequent dressing changes and a hydrating gel can decrease pain and make dressing changes a faster and more comfortable process. The antimicrobial preservation property of Hemastyl gel is an added bonus for patients.
Latest News
Read Latest News
This section features updates from our team, insights on product development, and announcements as Hemastyl® progresses through clinical, regulatory, and commercial milestones. Stay connected as we share news, company developments, and future resources designed to support clinicians and patients alike.